The ROE as of September 2024 (TTM) for InMed Pharmaceuticals Inc. (INM) is -53.37%

According to InMed Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current ROE is -53.37%. This represents a change of 278.66% compared to the average of -14.09% of the last 4 quarters.

InMed Pharmaceuticals Inc. (INM) Historical ROE (quarterly & annually)

How has INM ROE performed in the past?

The mean historical ROE of InMed Pharmaceuticals Inc. over the last ten years is -137.07%. The current -53.37% ROE has changed -61.07% with respect to the historical average. Over the past ten years (40 quarters), INM's ROE was at its highest in in the June 2023 quarter at -2.80%. The ROE was at its lowest in in the March 2015 quarter at -142.58%.

InMed Pharmaceuticals Inc. (INM) ROE by Quarter and Year

Discovering the peaks and valleys of InMed Pharmaceuticals Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

InMed Pharmaceuticals Inc. (INM) Average ROE

How has INM ROE performed in the past?

The current ROE of InMed Pharmaceuticals Inc. (INM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

InMed Pharmaceuticals Inc. (INM) ROE vs. Peers

How is INM’s ROE compared to its peers?

InMed Pharmaceuticals Inc.’s ROE is greater than Quoin Pharmaceuticals, Ltd. (-112.11%), greater than Allarity Therapeutics, Inc. (-704.78%), less than Kiromic BioPharma, Inc. (337.72%), greater than Virax Biolabs Group Limited (-115.10%), greater than Biodexa Pharmaceuticals Plc (-141.90%), less than SeaStar Medical Holding Corporation (323.08%), greater than Virios Therapeutics, Inc. (-130.35%), greater than ZyVersa Therapeutics, Inc. (-172.51%), greater than Sonnet BioTherapeutics Holdings, Inc. (-398.33%), greater than Revelation Biosciences, Inc. (-243.91%), greater than Palisade Bio, Inc. (-124.86%), greater than Bright Minds Biosciences Inc. (-58.27%), greater than Tonix Pharmaceuticals Holding Corp. (-158.27%), greater than Immix Biopharma, Inc. (-86.48%), greater than Phio Pharmaceuticals Corp. (-142.68%), less than 180 Life Sciences Corp. (3.04%), greater than Navidea Biopharmaceuticals, Inc. (-63.06%), greater than Sigilon Therapeutics, Inc. (-81.98%), greater than NovaBay Pharmaceuticals, Inc. (-431.13%), greater than GeoVax Labs, Inc. (-852.58%),

Build a custom stock screener for InMed Pharmaceuticals Inc. (INM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InMed Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

InMed Pharmaceuticals Inc. (INM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like InMed Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.